Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vacuuming the periplasm

Olga Lomovskaya1, Maxim Totrov

  • 1Mpex Pharmaceuticals, Inc., 5500 Campanile Dr., San Diego, CA 92182, USA. olomovskaya@mpexpharma.com

Journal of Bacteriology
|March 4, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of an Orally Efficacious Imidazo[4,5-<i>c</i>]pyridine-6-Carboxamide Antimalarial with a High Barrier to Resistance.

Journal of medicinal chemistry·2026
Same author

Characterization of β-Carboline Derivatives Reveals a High Barrier to Resistance and Potent Activity against Ring-Stage and DHA-Induced Dormant <i>Plasmodium falciparum</i>.

ACS infectious diseases·2025
Same author

Novel GPU Engines for Virtual Screening of Giga-Sized Libraries Identify Inhibitors of Challenging Targets.

Journal of chemical information and modeling·2025
Same author

Benzo-ring modification on Malaria Box hit MMV008138: effects on antimalarial potency and microsomal stability.

RSC medicinal chemistry·2025
Same author

Solvent-, enzyme-, and structural-dependence of phenyl-substituted methyl carbamate inhibition of acetylcholinesterase.

Insect biochemistry and molecular biology·2025
Same author

Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity.

ACS infectious diseases·2025